The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost The post Awakn set to research...
Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in the delivery of psychedelic therapies, today announced that Ronan Levy, Chairman...
The article Awakn’s Phase 3 Trial Launching With UK National Health Service was originally published on Microdose. Awakn Life Sciences has announced...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
The article News You Might Have Missed: Dec 12th 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
Irwin Naturals Inc. (CSE: IWIN | OTC: IWINF | FRA: 97X) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center....
The drug development company inspires psychedelics experts, but struggles to raise funds for its ketamine-assisted therapies and addiction treatments. The...
Awaken Life Sciences is trying to ride out a tough market for investment capital and raise funds for its ketamine-assisted therapies and addiction treatments. The...
Effect of psychedelics treatment goes beyond the immediate mental health diagnosis. The post Psychedelics Therapy More Than Just a Quick Fix appeared first...
Insurance coverage would expand access for the expensive treatments. The post Medical Insurance Providers Assess Benefits of Psychedelics Treatments appeared...